In the past decades, due to the advances of cancer genomics, a group of gene alterations is identified as driver gene mutations for LUAD, such as mutations in epidermal growth factor receptor (EGFR), c-MET, KRAS, anaplastic lymphoma kinase (ALK) [3–7]. This evidence concerns the gene EGFR and cancer.